Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000017

CEO bought 103,500 shares at an average $0.02 ($2,040)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

20 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-05 Purchase : show line 1 in the form +5,000 $0.02 $104 21,694,623 D
2019-03-05 Purchase : show line 2 in the form +10,000 $0.02 $210 21,704,623 D
2019-03-05 Purchase : show line 3 in the form +500 $0.02 $10 21,705,123 D
2019-03-05 Purchase : show line 4 in the form +15,000 $0.02 $311 21,720,123 D
2019-03-05 Purchase : show line 5 in the form +1,000 $0.02 $21 21,721,123 D
2019-03-06 Purchase : show line 6 in the form +5,000 $0.02 $93 21,726,123 D
2019-03-06 Purchase : show line 7 in the form +10,000 $0.02 $188 21,736,123 D
2019-03-06 Purchase : show line 8 in the form +500 $0.02 $9 21,736,623 D
Open-market purchases · 103,500 sh · avg $0.02 · $2,040
Loading xslF345X03/primary_doc.xml…